- About
- PsychU For You
- Topics
- Events
- Content
Comorbidities In Patients Living With Bipolar I Disorder
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Comorbidities In Patients Living With Bipolar I Disorder
Lifetime comorbidity rates in bipolar disorder are ~90%, and nearly half of these patients are treated for a minimum of three1. During this webinar, Otsuka Sr. MSL Dr. Michael Aldape will be talking with Dr. Joseph Goldberg who will guide us on a lively discussion addressing the complexities of psychiatric comorbidities associated with bipolar I disorder. This moderated session will explore common comorbidities, treatment options and the current guidelines for managing comorbid bipolar I patients.
1. Altinbas, K. Treatment of Comorbid Psychiatric Disorders with Bipolar Disorder. Noro Psikiyatr Ars. 2021 Sep 20;58 (Suppl 1): S41-S46.
Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
MoreJoseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”
Michael Aldape, PhD (OPDC)
Senior Medical Science Liaison
Speaker Joseph F Goldberg, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Michael Aldape, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
Registration
- PsychU For You
